benzoxazoles has been researched along with Metabolic Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fruchart, JC; Fruchart-Najib, J; Hermans, MP; Kodama, T | 1 |
| Akter, J; An, HJ; Chun, P; Chung, HY; Jeong, HO; Kim, DH; Kim, MJ; Kim, SJ; Lee, B; Lee, EK; Lee, HJ; Moon, HR; Moon, KM; Ullah, S; Yang, J | 1 |
| Audano, M; Botta, M; Mitro, N; Ruscica, M; Sahebkar, A; Sirtori, CR | 1 |
2 review(s) available for benzoxazoles and Metabolic Syndrome
| Article | Year |
|---|---|
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMĪ±) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
Topics: Animals; Benzoxazoles; Butyrates; Humans; Metabolic Syndrome; PPAR alpha | 2021 |
PPAR Agonists and Metabolic Syndrome: An Established Role?
Topics: Animals; Benzoxazoles; Butyrates; Chalcones; Drug Discovery; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lipid Metabolism; Lipids; Metabolic Syndrome; Peroxisome Proliferator-Activated Receptors; Propionates; Thiazolidinediones; Triglycerides | 2018 |
1 other study(ies) available for benzoxazoles and Metabolic Syndrome
| Article | Year |
|---|---|
Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
Topics: Acetyl-CoA Carboxylase; Animals; Benzoxazoles; Body Weight; Diabetes Mellitus; Enzyme Activators; Fatty Acid Synthases; Fatty Liver; Gene Expression Regulation; Glucose Intolerance; Heterocyclic Compounds, 4 or More Rings; Hypoglycemic Agents; Male; Metabolic Syndrome; Mice, Inbred C57BL; Molecular Docking Simulation; Resveratrol; Sirtuin 1; Sterol Regulatory Element Binding Proteins; Stilbenes | 2018 |